A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum Read more about A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum
DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis Read more about DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis
An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants Read more about An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants
Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine Read more about Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine
Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis Read more about Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis
Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients Read more about Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients Read more about An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study) Read more about A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair) Read more about A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)